Publication
188Re-PEI-MP as potential agent for metabolic radiotherapy
| dc.contributor.author | Ferreira, Sara | |
| dc.contributor.author | Abrantes, Ana Margarida | |
| dc.contributor.author | Metello, Luís F. | |
| dc.contributor.author | Zeevart, Jan | |
| dc.contributor.author | Louw, Werner | |
| dc.contributor.author | Dormehl, Irene D. | |
| dc.contributor.author | Botelho, Maria Filomena | |
| dc.date.accessioned | 2015-01-30T14:29:08Z | |
| dc.date.available | 2015-01-30T14:29:08Z | |
| dc.date.issued | 2010-10-15 | |
| dc.description.abstract | Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of high energy beta-particles. The development of watersoluble bone-seeking polymers such as PEI-MP (polyethyleneimine, functionalised with methylphosphonate-groups) that might be labeled with 188Re are recent approaches, with a strong potential for bone cancer treatment. The aim of this study was to evaluate the efficacy of 188Re-PEI-MP, as therapeutic agent for osteosarcoma, through in vitro and in vivo models. | por |
| dc.identifier.uri | http://hdl.handle.net/10400.22/5544 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.title | 188Re-PEI-MP as potential agent for metabolic radiotherapy | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | International | por |
| oaire.citation.title | Birmingham 2011 - Annual Congress of the European Association of Nuclear Medicine | por |
| rcaap.rights | openAccess | por |
| rcaap.type | conferenceObject | por |